Primary care outreach and decision counseling for lung cancer screening
Journal of Medical Screening · 2024
DOI: 10.1177/09691413231213495 ↗Kurz gefasst
Klinische Studie in der Zeitschrift Journal of Medical Screening, 2024. Verfasst von Heather Bittner Fagan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Family and Community Medicine, ChristianaCare Health Services, Inc., Wilmington, DE, USA. Hauptthemen laut MEDLINE: Lung Neoplasms, Primary Health Care, Early Detection of Cancer, Counseling. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, National Institute of General Medical Sciences.
Abstract (Originalsprache)
Introduction
Lung cancer screening rates are very low despite a level B recommendation from the United States Preventive Services Task Force since 2013 and clear evidence that lung cancer screening reduces mortality. The Center for Medicare and Medicaid Services requires shared decision-making (SDM) for lung cancer screening reimbursement. The objective of this study was to determine the effect of an SDM intervention on lung cancer screening in primary care.
Methods
The study design was a single-arm clinical trial design. The intervention included phone contact outside of a primary care visit and the use of the Decision Counseling Program ®, an online interactive decision aid focused on determining the factors which influence patients to screen or not screen, prioritizing those factors, and determining a decision preference score. The primary outcome was the completion of low-dose computed tomography scan (LDCT) 1 year after the SDM session compared in participants versus nonparticipants.
Results
From six practices, there were 1359 potentially eligible patients in electronic medical record data, and 336 were reached to assess eligibility criteria. A total of 80 patients consented to be in the study, 64 completed a decision counseling session and 16 did not complete a session. Among the 64 people who agreed to have decision counseling, 45% had LDCT, higher than typically seen in routine clinical practice. Although not a comparable group, among the 16 people who declined decision counseling, none had LDCT.
Conclusions
Decision counseling is a promising intervention that might support SDM in the context of improving uptake of lung cancer screening in primary care. However, further, larger studies are needed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Family and Community Medicine, ChristianaCare Health Services, Inc., Wilmington, DE, USA.
- Institute for Research in Equity and Community Health (iREACH), ChristianaCare Health Services, Inc., Wilmington, DE, USA.
- Department of Behavioral Health and Nutrition, College of Health Sciences, University of Delaware, Newark, DE, USA.
- ChristianaCare Health Services, Inc., Wilmington, DE, USA.
- Department of Medical Oncology, Thomas Jefferson University, Philadelphia, PA, USA.
ORCID-Profile: Heather Bittner Fagan, L Anna Thompson
Förderung
- NIGMS NIH HHS
- National Institute of General Medical Sciences
Zitieren
APA
Bittner Fagan, H., Jurkovitz, C., Zhang, Z., Thompson, L. A., Patterson, F., Zazzarino, M. A., & Myers, R. E. (2024). Primary care outreach and decision counseling for lung cancer screening. Journal of Medical Screening. https://doi.org/10.1177/09691413231213495
Vancouver
Bittner Fagan H, Jurkovitz C, Zhang Z, Thompson LA, Patterson F, Zazzarino MA, et al. Primary care outreach and decision counseling for lung cancer screening. Journal of Medical Screening. 2024. doi:10.1177/09691413231213495
BibTeX
@article{BittnerFagan2024,
author = {Bittner Fagan, Heather and Jurkovitz, Claudine and Zhang, Zugui and Thompson, L Anna and Patterson, Freda and Zazzarino, Martha A and Myers, Ronald E},
title = {Primary care outreach and decision counseling for lung cancer screening},
journal = {Journal of Medical Screening},
year = {2024},
doi = {10.1177/09691413231213495}
}
EUVIMED